Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intersect ENT Inc (NASDAQ:XENT)

13.35
Delayed Data
As of Jan 13
 +0.20 / +1.52%
Today’s Change
7.65
Today|||52-Week Range
20.64
+10.33%
Year-to-Date
No recent news for Intersect ENT Inc.

Today’s Trading

Previous close13.15
Today’s open13.20
Day’s range13.20 - 13.78
Volume196,930
Average volume (3 months)329,927
Market cap$381.3M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)+36.65%
Earnings growth (this year)+9.58%
Earnings growth (next 5 years)-15.33%
Revenue growth (last year)+59.67%
P/E ratioNM
Price/Sales9.73
Price/Book2.89

Competitors

 Today’s
change
Today’s
% change
SRDXSurModics Inc+0.30+1.22%
ATRSAntares Pharma Inc-0.11-5.00%
CERSCerus Corp+0.04+0.94%
RMTIRockwell Medical Inc-0.15-2.41%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$60.5M
Annual profit (last year)-$26.6M
Net profit margin-44.03%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs